SCHEMBL22025652

SCHEMBL22025652

CC#CCCC/C=C/C1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1

nearest known ligand 0.62

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ PTGER4 P35408 15/20 0.62
▸ PTGER2 P43116 12/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18943887 0.87 PTGER4 (0.75) PTGER4PTGER2
SCHEMBL15586948 0.87 PTGER4 (0.78) PTGER4PTGER2
SCHEMBL16819317 0.87 PTGER4 (0.78) PTGER4PTGER2
SCHEMBL19328525 0.87 PTGER4 (0.78) PTGER4PTGER2
SCHEMBL16819314 0.87 PTGER4 (0.78) PTGER4PTGER2
SCHEMBL22025493 0.86 PTGER4 (0.66) PTGER4PTGER2
SCHEMBL18943146 0.85 PTGER4 (0.71) PTGER4PTGER2
SCHEMBL22024730 0.84 PTGER4 (0.72) PTGER4PTGER2
SCHEMBL16819176 0.82 PTGER4 (0.87) PTGER4PTGER2
SCHEMBL16819178 0.82 PTGER4 (0.87) PTGER4PTGER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3176162-B1 DIFLUOROLACTAM COMPOUNDS AS EP4 RECEPTOR-SELECTIVE AGONISTS FOR USE IN THE TREATMENT OF EP4-MEDIATED DISEASE AND CONDITIONS CAYMAN CHEMICAL CO INC (US) 2020-05-27 — — EP disclosed
Send feedback